Treatment of Epistaxis
The first-line treatment for epistaxis is firm sustained compression to the lower third of the nose for 10-15 minutes, which should be attempted before proceeding to other interventions. 1
Initial Management Algorithm
First-line approach:
- Apply firm pressure to the lower third of the nose for 10-15 minutes
- Patient should be seated leaning forward to avoid blood flowing down the throat
- Consider applying ice packs to the nasal bridge to promote vasoconstriction
If bleeding persists:
- Apply vasoconstrictor spray such as oxymetazoline (Afrin) 2 to help constrict blood vessels, with a success rate of 65-75% 1, 3
- Topical tranexamic acid may be particularly effective in patients on antiplatelet therapy 1 and has shown superior results compared to other topical agents in stopping bleeding within 10 minutes 4
Cauterization and Advanced Techniques
If the initial measures fail to control bleeding and a specific bleeding site can be identified:
- Cauterization is preferred over nasal packing 1
Nasal Packing
For bleeding that cannot be controlled by compression, vasoconstrictors, or cauterization:
Options include:
Important considerations:
- Monitor for complications including infection, decreased blood flow, septal perforations, pressure sores, and worsening of obstructive sleep apnea 1
- Patients with anterior nasal packing may be discharged with appropriate antibiotics and follow-up
- Posterior packing typically requires hospital admission for monitoring
Management of Persistent or Severe Bleeding
For intractable cases not responding to the above measures:
- Endoscopic arterial ligation targeting the sphenopalatine artery (SPA) has a 97% success rate compared to 62% with conventional nasal packing 1, 3
- Embolization may be considered with approximately 80% success rate but carries higher risk of serious complications including stroke (0.9-1.6%) 1
Special Considerations for Patients on Anticoagulants/Antiplatelets
- For patients on dual antiplatelet therapy with persistent bleeding, consider temporary discontinuation of one agent (preferably clopidogrel) in consultation with the prescribing physician 1
- Resumption of antiplatelet therapy should occur as soon as bleeding is controlled 1
- Topical tranexamic acid has shown particular benefit in these patients 1, 5
Post-Treatment Care and Prevention
- Nasal moisturization with saline gel or spray 1-3 times daily
- Humidification in dry environments
- Avoid digital trauma (nose picking) and vigorous nose blowing 1
When to Refer to Specialist or Emergency Department
- Posterior epistaxis
- Bleeding not controlled with anterior packing
- Recurrent epistaxis despite treatment
- Suspected underlying pathology requiring endoscopic evaluation 1
Warning Signs Requiring Immediate Attention
- Return of blood from nose or mouth
- Fever over 101°F
- Increasing pain
- Vision changes
- Shortness of breath
- Loss of color around the skin of the nose
- Swelling of the face
- Diffuse skin rash 1
Important note: Recent research suggests that topical tranexamic acid at a dose of 1000 mg may be more effective than 500 mg, with decreased rates of recurrent bleeding and low incidence of side effects 6. This represents a promising advancement in epistaxis management that could be incorporated into treatment protocols.